Logo image of ALGEC.PA

GECI INTERNATIONAL (ALGEC.PA) Stock Fundamental Analysis

EPA:ALGEC - Euronext Paris - Matif - FR001400M1R1 - Common Stock - Currency: EUR

4.125  -0.3 (-6.88%)

Fundamental Rating

3

Overall ALGEC gets a fundamental rating of 3 out of 10. We evaluated ALGEC against 29 industry peers in the Professional Services industry. ALGEC has a bad profitability rating. Also its financial health evaluation is rather negative. ALGEC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALGEC had positive earnings in the past year.
In the past year ALGEC had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALGEC reported negative net income in multiple years.
ALGEC had negative operating cash flow in 4 of the past 5 years.
ALGEC.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

ALGEC has a better Return On Assets (6.42%) than 68.97% of its industry peers.
ALGEC has a Return On Equity of 19.84%. This is in the better half of the industry: ALGEC outperforms 68.97% of its industry peers.
Industry RankSector Rank
ROA 6.42%
ROE 19.84%
ROIC N/A
ROA(3y)-2.06%
ROA(5y)-5.64%
ROE(3y)-30.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGEC.PA Yearly ROA, ROE, ROICALGEC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

ALGEC's Profit Margin of 4.65% is fine compared to the rest of the industry. ALGEC outperforms 62.07% of its industry peers.
ALGEC's Profit Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 19.83%, ALGEC is doing worse than 62.07% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGEC has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 4.65%
GM 19.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.57%
PM growth 5YN/A
GM growth 3Y-5.81%
GM growth 5Y-7.26%
ALGEC.PA Yearly Profit, Operating, Gross MarginsALGEC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

ALGEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGEC has more shares outstanding
Compared to 5 years ago, ALGEC has less shares outstanding
The debt/assets ratio for ALGEC has been reduced compared to a year ago.
ALGEC.PA Yearly Shares OutstandingALGEC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
ALGEC.PA Yearly Total Debt VS Total AssetsALGEC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.41, we must say that ALGEC is in the distress zone and has some risk of bankruptcy.
ALGEC has a Altman-Z score of 0.41. This is amonst the worse of the industry: ALGEC underperforms 82.76% of its industry peers.
ALGEC has a debt to FCF ratio of 5.92. This is a neutral value as ALGEC would need 5.92 years to pay back of all of its debts.
The Debt to FCF ratio of ALGEC (5.92) is comparable to the rest of the industry.
ALGEC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALGEC (0.14) is better than 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 5.92
Altman-Z 0.41
ROIC/WACCN/A
WACC5.51%
ALGEC.PA Yearly LT Debt VS Equity VS FCFALGEC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ALGEC has a Current Ratio of 0.80. This is a bad value and indicates that ALGEC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.80, ALGEC is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
A Quick Ratio of 0.80 indicates that ALGEC may have some problems paying its short term obligations.
ALGEC has a Quick ratio of 0.80. This is in the lower half of the industry: ALGEC underperforms 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
ALGEC.PA Yearly Current Assets VS Current LiabilitesALGEC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

2

3. Growth

3.1 Past

ALGEC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.72%, which is quite impressive.
Looking at the last year, ALGEC shows a quite strong growth in Revenue. The Revenue has grown by 10.43% in the last year.
The Revenue has been decreasing by -5.29% on average over the past years.
EPS 1Y (TTM)114.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.79%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y10.84%
Revenue growth 5Y-5.29%
Sales Q2Q%-17.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEC.PA Yearly Revenue VS EstimatesALGEC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ALGEC.PA Yearly EPS VS EstimatesALGEC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.73, the valuation of ALGEC can be described as very cheap.
Based on the Price/Earnings ratio, ALGEC is valued cheaply inside the industry as 96.55% of the companies are valued more expensively.
ALGEC is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.73
Fwd PE N/A
ALGEC.PA Price Earnings VS Forward Price EarningsALGEC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALGEC is valued a bit cheaper than the industry average as 72.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.11
EV/EBITDA N/A
ALGEC.PA Per share dataALGEC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALGEC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GECI INTERNATIONAL

EPA:ALGEC (3/7/2025, 7:00:00 PM)

4.125

-0.3 (-6.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.57%
Ins Owner ChangeN/A
Market Cap4.21M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.73
Fwd PE N/A
P/S 0.19
P/FCF 10.11
P/OCF 9.58
P/B 0.79
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.72
EY17.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY9.89%
OCF(TTM)0.43
OCFY10.43%
SpS22.28
BVpS5.22
TBVpS-1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.42%
ROE 19.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 4.65%
GM 19.83%
FCFM 1.83%
ROA(3y)-2.06%
ROA(5y)-5.64%
ROE(3y)-30.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y1.57%
PM growth 5YN/A
GM growth 3Y-5.81%
GM growth 5Y-7.26%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 5.92
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 39.39%
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 0.41
F-Score6
WACC5.51%
ROIC/WACCN/A
Cap/Depr(3y)74.78%
Cap/Depr(5y)48.89%
Cap/Sales(3y)0.72%
Cap/Sales(5y)0.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.43%
Revenue growth 3Y10.84%
Revenue growth 5Y-5.29%
Sales Q2Q%-17.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3130.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y138.17%
OCF growth 3YN/A
OCF growth 5YN/A